Reuters logo
BRIEF-Tonix Pharmaceuticals presented new clinical results from sub-group analysis of phase 2 AtEase study in military-related posttraumatic stress disorder (PTSD)
December 8, 2016 / 12:19 PM / a year ago

BRIEF-Tonix Pharmaceuticals presented new clinical results from sub-group analysis of phase 2 AtEase study in military-related posttraumatic stress disorder (PTSD)

Dec 8 (Reuters) - Tonix Pharmaceuticals Holding Corp

* Tonix Pharmaceuticals presented new clinical results from sub-group analysis of phase 2 AtEase study in military-related posttraumatic stress disorder (PTSD)

* Tonix says remains on target to initiate first of two 12-week, randomized, double-blind, placebo-controlled phase 3 studies in military-related PTSD in Q1 of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below